Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression.  Gelsolin is non-immunosuppressive unlike current treatments to quell...

Arch Biopartners Releases New Video Showing Metablok Reducing Lung Inflammation in an Animal Model TORONTO, March 31, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company developing new drug candidates for treating...

Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United...